Clinical Trial Update: Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and Obesity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of HRS-7535 in adults with heart failure with reduced or preserved ejection fraction and obesity, cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Heart Failure with Reduced Ejection Fraction
• Obesity

Drugs mentioned

• HRS-7535 (HRS-7535)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity | Phase 2 | Status: RECRUITING